Please assess the completion status of the following clinical trial:

Trial Title: Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent~* Successful completion of study protocol 3104001~* Response or stable disease in study 3104001 at week 12~Exclusion Criteria:~* New serious concurrent medical condition~* Not able to swallow the study drug

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ODM-201 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).